Kristin Bloink

Vice President, Product Development

Kristin Bloink is Vice President of Development at BiomEdit. She is a seasoned leader in animal health innovation with nearly two decades of industry experience spanning biologics, small molecules, and nutritional projects/products across companion animals, farm species, and aquaculture. She began her industry career in clinical development, external innovation, and project leadership at Novartis Animal Health, ultimately advancing into multiple vice president roles overseeing research, external innovation, development, and regulatory/pharmacovigilance at Elanco.

A practicing veterinarian for 20 years and former physician assistant in both private practice and the military, Kristin served in the U.S. Army Specialty Corps as a physician assistant and the U.S. Army Veterinary Corps as a veterinarian, bringing a rare depth of translational medicine expertise, as a clinician and a career-long commitment to moving breakthrough science from concept to patient, animal, or human.

She joined BiomEdit in 2025 to reengage with the microbiome technology platform she helped build at Elanco. Today, she leads product development, driving Clostridium Perfringens Alpha Toxin and NetB Antibody Fragment, Live Limosilactobacillus Vector or CPerf LLV* (aka BE-101), the company’s first registered product, toward market launch and establishing the foundations for sustained commercial success. Her work reflects both scientific rigor and a deep passion for innovation that meaningfully improves health and productivity outcomes.

She holds a DVM from Michigan State University College of Veterinary Medicine.